Form 4: Hims & Hers Health COO Melissa Baird Executes Stock Option Exercises and Sales
SEC Form 4 Filing
Chief Operating Officer of Hims & Hers Health, Melissa Baird, reports exercising stock options and selling Class A Common Stock between March 5th and March 7th, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- Between March 5th and March 7th, 2024, Baird exercised stock options to acquire Class A Common Stock at a price of $0.40 per share.
- Concurrently, she sold portions of her Class A Common Stock holdings at prices ranging from $13.55 to $14.66 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2023.
- The reported transactions resulted in a net change in Baird's holdings of Class A Common Stock, with the final amount beneficially owned being 507,465 shares.
- She also continues to hold options to purchase 775,411 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions by an officer under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates any significant concerns.
Key Dates
| Date | Description |
|---|---|
| 2023-11-21 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-03-05 | Date of first reported transaction (stock option exercise and sale). |
| 2024-03-06 | Date of second reported transaction (stock option exercise and sale). |
| 2024-03-07 | Date of last reported transaction (stock option exercise and sale). |
| 2028-03-28 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.